首页 文献索引 SCI期刊 AI助手
首页 正文

Expert review of anti-infective therapy. 2020 Aug;18(8):817-822. doi: 10.1080/14787210.2020.1758557 Q13.82025

Role of Ribavirin in the Era of Direct-Acting Antiviral Therapies of Chronic Hepatitis C

直接抗病毒疗法时代 ribavirin 治疗慢性丙型肝炎的作用分析 翻译改进

Omkolsoum Alhaddad  1, Ahmed Wahb  1, Alyaa Sabry  1, Fatma Khalil  2, Dalia Elsabaawy  3, Helmy Elshazly  1, Nashwa Shebl, Mohamed Rady  1, Maha Elsabaawy  1

作者单位 +展开

作者单位

  • 1 Department of Hepatology, National Liver Institute, Menoufia University , Shebin El-kom, Egypt.
  • 2 Department of Microbiology and Immunology, National Liver Institute, Menoufia University , Shebin El-kom, Egypt.
  • 3 Department of Clinical Pharmacy, Pharmacy College, Menoufia University , Shebin El-kom, Egypt.

    • DOI: 10.1080/14787210.2020.1758557 PMID: 32397842

    摘要 Ai翻译

    Background: The efficacy of adding ribavirin (RBV) to direct antivirals (DAAs) in HCV treatment is still debatable, with allegations of insecure profiles. Objectives: To evaluate safety and efficacy of RBV in the era of DAAs in chronic HCV Egyptian patients. Methods: ... ...点击完成人机验证后继续浏览
    Copyright © Expert review of anti-infective therapy. 中文内容为AI机器翻译，仅供参考！

    相关内容

    期刊名：Expert review of anti-infective therapy

    缩写：EXPERT REV ANTI-INFE

    ISSN：1478-7210

    e-ISSN：1744-8336

    IF/分区：3.8/Q1

    文章目录 更多期刊信息

    全文链接
    官方链接
    PMC全文
    引文链接
    复制
    已复制！
    推荐内容
    Role of Ribavirin in the Era of Direct-Acting Antiviral Therapies of Chronic Hepatitis C